Nemaura Medical Inc. (NMRD) Financial Statements (2026 and earlier)

Company Profile

Business Address 57 WEST 57TH STREET
MANHATTAN, NY 10019
State of Incorp.
Fiscal Year End March 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2023
3/31/2022
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments17,74931,8651063,741822911
Cash and cash equivalent17,74931,8651063,741822911
Receivables101     
Inventory, net of allowances, customer advances and progress billings1,48885128638  
Inventory1,48885128638  
Prepaid expense 474593352   
Advance royalties      
Other undisclosed current assets2766771017365,1761,919
Total current assets:20,08833,9868454,5155,9992,830
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization      
Intangible asset, including goodwill, after accumulated amortization      
Intangible asset, excluding goodwill, after accumulated amortization      
Other noncurrent assets 2,0131,257375249257213
Other undisclosed noncurrent assets      4,359
Total noncurrent assets:2,0131,2573752492574,572
TOTAL ASSETS:22,10235,2431,2204,7646,2557,402
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1362542941615078
Accounts payable1362542941615078
Deferred revenue25910393
Debt19,1895,733    
Other liabilities 99918116910814887
Due to related parties  149830965614688
Other undisclosed current liabilities   65  
Total current liabilities:20,5836,4201,3861,299811852
Noncurrent Liabilities
Long-term debt and lease obligation 19,189    
Long-term debt, excluding current maturities 19,189    
Liabilities, other than long-term debt     1,3331,183
Deferred revenue and credits1,3331,183
Other undisclosed noncurrent liabilities1,0531,2761,1471,238  
Total noncurrent liabilities:1,05320,4651,1471,2381,3331,183
Total liabilities:21,63626,8852,5332,5372,1442,035
Equity
Equity, attributable to parent4668,358(1,313)2,2274,1115,367
Preferred stock     0 
Common stock24232120868205
Additional paid in capital38,29632,04416,58915,78513,05712,920
Accumulated other comprehensive income (loss)(122)136(337)(340)(41)(606)
Accumulated deficit(37,731)(23,845)(17,586)(13,426)(8,973)(7,153)
Total equity:4668,358(1,313)2,2274,1115,367
TOTAL LIABILITIES AND EQUITY:22,10235,2431,2204,7646,2557,402

Income Statement (P&L) ($ in thousands)

3/31/2023
3/31/2022
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
Revenues504 42489 
Net investment income   42489 
Cost of revenue
(Cost of Product and Service Sold)
(344)     
Other undisclosed gross profit      
Gross profit:160 42489 
Operating expenses(7,730)(4,587)(4,778)(4,477)(1,909)(1,551)
Other undisclosed operating loss   (4)(24)(89) 
Operating loss:(7,570)(4,587)(4,778)(4,477)(1,909)(1,551)
Nonoperating income (expense)
(Gain (Loss), Foreign Currency Transaction, before Tax)
    2699(994)
Loss from continuing operations before equity method investments, income taxes:(7,570)(4,587)(4,778)(4,451)(1,810)(2,545)
Other undisclosed income (loss) from continuing operations before income taxes(6,667)(2,008)4(2)(10)994
Loss from continuing operations before income taxes:(14,237)(6,594)(4,775)(4,453)(1,820)(1,551)
Income tax benefit350336614   
Loss from continuing operations:(13,887)(6,259)(4,160)(4,453)(1,820)(1,551)
Loss before gain (loss) on sale of properties:(13,887)(6,259)(4,160)(4,453)(1,820)(1,551)
Other undisclosed net loss      
Net loss available to common stockholders, diluted:(13,887)(6,259)(4,160)(4,453)(1,820)(1,551)

Comprehensive Income ($ in thousands)

3/31/2023
3/31/2022
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
Net loss:(13,887)(6,259)(4,160)(4,453)(1,820)(1,551)
Other comprehensive income (loss) (440)  (299)565(761)
Comprehensive loss:(14,327)(6,259)(4,160)(4,752)(1,256)(2,312)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1824733   
Comprehensive loss, net of tax, attributable to parent:(14,145)(5,786)(4,157)(4,752)(1,256)(2,312)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: